139 related articles for article (PubMed ID: 31992849)
1. Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation.
Yan CH; Wang Y; Mo XD; Sun YQ; Wang FR; Fu HX; Chen Y; Han TT; Kong J; Cheng YF; Zhang XH; Xu LP; Liu KY; Huang XJ
Bone Marrow Transplant; 2020 Jun; 55(6):1147-1160. PubMed ID: 31992849
[TBL] [Abstract][Full Text] [Related]
2. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation.
Xhaard A; Robin M; Scieux C; de Latour RP; Deplus S; Mazeron MC; Devergie A; Espérou H; Rocha V; Gluckman E; Ribaud P; Socié G
Transplantation; 2007 Jan; 83(1):80-3. PubMed ID: 17220797
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus retinitis in children and adolescents with acute leukemia following allogeneic hematopoietic stem cell transplantation.
Zöllner SK; Herbrüggen H; Kolve H; Mihailovic N; Schubert F; Reicherts C; Rössig C; Groll AH
Transpl Infect Dis; 2019 Oct; 21(5):e13089. PubMed ID: 30972869
[TBL] [Abstract][Full Text] [Related]
5. Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide.
Huntley D; Giménez E; Pascual MJ; Hernández-Boluda JC; Gago B; Vázquez L; Piñana JL; García M; Pérez A; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Transpl Infect Dis; 2020 Feb; 22(1):e13206. PubMed ID: 31677215
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation.
Meng XY; Fu HX; Zhu XL; Wang JZ; Liu X; Yan CH; Zhang YY; Mo XD; Wang Y; Han W; Chen YH; Chen DB; Liu HX; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
Ann Hematol; 2020 Nov; 99(11):2659-2670. PubMed ID: 32734550
[TBL] [Abstract][Full Text] [Related]
7. Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia.
Lin CH; Su YJ; Hsu CY; Wang PN; Teng CJ
Transpl Infect Dis; 2019 Aug; 21(4):e13096. PubMed ID: 31004545
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.
Jeon S; Lee WK; Lee Y; Lee DG; Lee JW
Ophthalmology; 2012 Sep; 119(9):1892-8. PubMed ID: 22657564
[TBL] [Abstract][Full Text] [Related]
9. Continuous High-Dose (6 mg) vs. Low-Dose (3 mg) Intravitreal Ganciclovir for Cytomegalovirus Retinitis After Haploidentical Hematopoietic Stem Cell Transplantation: A Randomized Controlled Study.
Chen WB; Long Z; Hou J; Miao H; Zhao MW
Front Med (Lausanne); 2021; 8():750760. PubMed ID: 35004721
[No Abstract] [Full Text] [Related]
10. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
[TBL] [Abstract][Full Text] [Related]
11. The Potential Association of Delayed T Lymphocyte Reconstitution Within Six Months Post-Transplantation With the Risk of Cytomegalovirus Retinitis in Severe Aplastic Anemia Recipients.
Mo W; Chen X; Zhang X; Wang S; Li L; Zhang Y
Front Cell Infect Microbiol; 2022; 12():900154. PubMed ID: 35694535
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cytomegalovirus Reactivation With or Without Acute Graft-Versus-Host Disease on the Risk of Nonrelapse Mortality.
Akahoshi Y; Kimura SI; Inamoto Y; Seo S; Muranushi H; Shimizu H; Ozawa Y; Tanaka M; Uchida N; Kanda Y; Katayama Y; Shiratori S; Ota S; Matsuoka KI; Onizuka M; Fukuda T; Atsuta Y; Murata M; Terakura S; Nakasone H
Clin Infect Dis; 2021 Aug; 73(3):e620-e628. PubMed ID: 33341890
[TBL] [Abstract][Full Text] [Related]
13. CMV Retinitis in Wiskott Aldrich Syndrome.
Luo J; Peng J; Zhao PQ; Fei P
Ocul Immunol Inflamm; 2023 Jan; 31(1):134-141. PubMed ID: 34878956
[TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors, and clinical outcomes associated with Epstein-Barr virus-DNAemia and Epstein-Barr virus-associated disease in patients after haploidentical allogeneic stem cell transplantation: A single-center study.
Zhou L; Gao ZY; Lu DP
Clin Transplant; 2020 Jun; 34(6):e13856. PubMed ID: 32170765
[TBL] [Abstract][Full Text] [Related]
15. [Influent factors for treating procedure of cytomegalovirus retinitis after allogeneic bone marrow hematopoietic stem cell transplantation].
Miao H; Hou J
Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):740-745. PubMed ID: 29050186
[No Abstract] [Full Text] [Related]
16. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus.
Chen Y; Xu LP; Liu KY; Chen H; Chen YH; Zhang XH; Wang Y; Wang FR; Han W; Wang JZ; Yan CH; Huang XJ
J Clin Virol; 2016 Feb; 75():10-5. PubMed ID: 26735213
[TBL] [Abstract][Full Text] [Related]
18. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Aqueous Interleukin-8-Guided Treatment in Cytomegalovirus Retinitis after Bone Marrow Hematopoietic Stem Cell Transplantation.
Zhang C; Wang YE; Miao H; Hou J
Ocul Immunol Inflamm; 2022 Apr; 30(3):758-765. PubMed ID: 33064057
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation.
Wang X; Lu Y; Li H; Ma Z; Hong J; Wang C
J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
